ResMed (RMD) Tops Q4 EPS by 4c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $188.63 --0%
EPS Growth %: +13.3%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +13.3%
Financial Fact:
Cost of sales: 196.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $1.49, $0.04 better than the analyst estimate of $1.45. Revenue for the quarter came in at $914.7 million versus the consensus estimate of $910.54 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
